M. A. Alsina

1.7k total citations
134 papers, 1.5k citations indexed

About

M. A. Alsina is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, M. A. Alsina has authored 134 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Molecular Biology, 41 papers in Hepatology and 38 papers in Epidemiology. Recurrent topics in M. A. Alsina's work include Lipid Membrane Structure and Behavior (76 papers), Influenza Virus Research Studies (29 papers) and Hepatitis C virus research (29 papers). M. A. Alsina is often cited by papers focused on Lipid Membrane Structure and Behavior (76 papers), Influenza Virus Research Studies (29 papers) and Hepatitis C virus research (29 papers). M. A. Alsina collaborates with scholars based in Spain, Hungary and United States. M. A. Alsina's co-authors include Isabel Haro, F. Reig, Yolanda Cajal, C. Mestres, Montserrat Pujol, Maria Antònia Busquets, María J. Gómara, Francesc Rabanal, M. Busquets and Marta Espina and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Physical Chemistry B and Biochemistry.

In The Last Decade

M. A. Alsina

133 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. A. Alsina Spain 19 965 215 211 186 176 134 1.5k
John L. Kulp United States 18 528 0.5× 174 0.8× 120 0.6× 118 0.6× 296 1.7× 41 1.1k
Masaki Yamada Japan 22 938 1.0× 322 1.5× 606 2.9× 173 0.9× 127 0.7× 146 2.7k
Min Liu China 28 801 0.8× 151 0.7× 168 0.8× 45 0.2× 119 0.7× 119 2.0k
Keliang Liu China 27 1.2k 1.3× 116 0.5× 352 1.7× 24 0.1× 562 3.2× 132 2.4k
Thomas Hermann United States 34 4.2k 4.3× 99 0.5× 380 1.8× 148 0.8× 61 0.3× 76 4.8k
Roger New United Kingdom 18 1.0k 1.1× 172 0.8× 242 1.1× 12 0.1× 339 1.9× 53 2.2k
Mingjun Huang United States 17 409 0.4× 167 0.8× 438 2.1× 129 0.7× 35 0.2× 59 1.6k
Reiko T. Lee United States 26 2.1k 2.1× 130 0.6× 1.1k 5.4× 50 0.3× 107 0.6× 60 2.9k
Ming‐Chu Hsu United States 19 838 0.9× 390 1.8× 147 0.7× 13 0.1× 135 0.8× 36 1.8k
A S Janoff United States 22 1.2k 1.2× 143 0.7× 217 1.0× 19 0.1× 655 3.7× 35 2.3k

Countries citing papers authored by M. A. Alsina

Since Specialization
Citations

This map shows the geographic impact of M. A. Alsina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. Alsina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. Alsina more than expected).

Fields of papers citing papers by M. A. Alsina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. A. Alsina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. Alsina. The network helps show where M. A. Alsina may publish in the future.

Co-authorship network of co-authors of M. A. Alsina

This figure shows the co-authorship network connecting the top 25 collaborators of M. A. Alsina. A scholar is included among the top collaborators of M. A. Alsina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. Alsina. M. A. Alsina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ariza‐Solé, Albert, Victòria Lorente, José Carlos Sánchez‐Salado, et al.. (2020). Hospitalization-related economic impact of patients with cardiogenic shock in a high-complexity reference centre. European Heart Journal Acute Cardiovascular Care. 10(1). 50–53. 9 indexed citations
2.
Cruz, Antonio, et al.. (2014). Surface behavior of peptides from E1 GBV-C protein: Interaction with anionic model membranes and importance in HIV-1 FP inhibition. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(2). 392–407. 6 indexed citations
3.
Domènech, Òscar, A. Ortiz, Montserrat Pujol, et al.. (2014). Modification of FP-HIV activity by peptide sequences of GB virus C: A biophysical approach. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1838(5). 1274–1280. 3 indexed citations
4.
Sánchez‐Martín, María‐Jesús, Antonio Cruz, M. Busquets, et al.. (2012). Physicochemical characterization of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide: Interaction with model membranes. International Journal of Pharmaceutics. 436(1-2). 593–601. 6 indexed citations
5.
Sánchez‐Martín, María‐Jesús, Patricia Urbán, Montserrat Pujol, et al.. (2011). Biophysical Investigations of GBV‐C E1 Peptides as Potential Inhibitors of HIV‐1 Fusion Peptide. ChemPhysChem. 12(15). 2816–2822. 10 indexed citations
6.
Pérez-López, Silvia, et al.. (2009). Behaviour of a peptide sequence from the GB virus C/hepatitis G virus E2 protein in Langmuir monolayers: Its interaction with phospholipid membrane models. Biophysical Chemistry. 141(2-3). 153–161. 14 indexed citations
7.
Sánchez‐Martín, María‐Jesús, José Manuel Amigo, Montserrat Pujol, et al.. (2009). Fluorescence study of the dynamic interaction between E1(145–162) sequence of hepatitis GB virus C and liposomes. Analytical and Bioanalytical Chemistry. 394(4). 1003–1010. 9 indexed citations
8.
Alsina, M. A., et al.. (2007). New GHK hydrophobic derivatives: Interaction with phospholipid bilayers. Colloids and Surfaces B Biointerfaces. 57(2). 243–249. 7 indexed citations
9.
Rabanal, Francesc, et al.. (2005). Synthesis and membrane action of polymyxin B analogues. Luminescence. 20(3). 117–123. 23 indexed citations
10.
Alsina, M. A., et al.. (2005). Synthesis and study of molecular interactions between phosphatidyl choline and two laminin derived peptides hydrophobically modified. Journal of Colloid and Interface Science. 294(2). 385–390. 13 indexed citations
11.
Busquets, Maria Antònia, M. A. Alsina, & Isabel Haro. (2003). Peptides and Liposomes: From Biophysical to Immunogenic Studies. Current Drug Targets. 4(8). 633–642. 8 indexed citations
12.
Muñoz-Mateu, Montserrat, et al.. (2001). Physicochemical study of a synthetic peptide belonging to human filaggrin protein. Journal de Physique IV (Proceedings). 11(PR10). Pr10–261. 1 indexed citations
13.
Garcı́a, Mónica, M. A. Alsina, F. Reig, & Isabel Haro. (1999). Liposomes as vehicles for the presentation of a synthetic peptide containing an epitope of hepatitis A virus. Vaccine. 18(3-4). 276–283. 16 indexed citations
15.
Garcı́a, Mónica, Montserrat Pujol, F. Reig, M. A. Alsina, & Isabel Haro. (1997). Interaction with Phospholipid Mono- and Bi-layers of HAV-VP3 (102-121) Sequence by Using Spectroscopic Techniques. Biomedical Chromatography. 11(2). 121–123. 2 indexed citations
16.
Haro, Isabel, et al.. (1997). Interaction of Polyethylenglycol Coated Liposomes and Plain Liposomes Studied using Fluorescent Probes. Biomedical Chromatography. 11(2). 75–76.
17.
Alsina, M. A., et al.. (1996). Coating liposomes with collagen (Mr 50 000) increases uptake into liver. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1279(2). 259–265. 46 indexed citations
18.
Cajal, Yolanda, et al.. (1992). Gentamicin Encapsulation in Liposomes: Factors Affecting the Efficiency. Journal of Liposome Research. 2(1). 11–22. 7 indexed citations
19.
Reig, F., et al.. (1989). Preparation andin vitroactivity of liposome encapsulated opioids. Journal of Microencapsulation. 6(3). 277–283. 5 indexed citations
20.
Reig, F., et al.. (1988). A physicochemical study of the interaction of phosphatidylinositol with buprenorphine and naloxone. Journal of Bioenergetics and Biomembranes. 20(4). 533–549. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026